Statement of fact -- he is paid by NWBO and is promoting the drug with the totally redone protocol and not referencing that fact. There have been 8 publications that have documented to trial defects. NWBO has violated FDA guidelines for oncology comparators.
Ashkan has numerous undisclosed conflicts of interests, that are very problematic , in regards to when he goes in for the hard sell of this 'vaccine' to vulnerable cancer patients. But that matter will be judged by the GMC Ethics Committee in due course ?
Market Data 
Markets 
AI
